Jackson Acquisition Company II (JACS)
Jackson Acquisition Company II (NYSE: JACS) is a common stock listing of a company with no significant operating business of its own. Incorporated in 2024 and based in Alpharetta, Georgia, it is structured to pursue a future business combination, such as a merger, share exchange, asset acquisition, share purchase, recapitalization, or reorganization, with one or more businesses or entities in the healthcare industry. As a listed company in the Financials sector and Capital Markets industry, its current profile is centered on identifying and completing a transaction rather than on ongoing commercial operations.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-JACS
|
$7.01
|
-34.9% Downside
|
Overvalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 13, 2026
|
37.4x
|
318.8 M
|
318.8 M
|
0.1%
|
75.4%
|
0.8
|
-4.3%
|
